Emergency Help!
Advanced
Search
  1. Home
  2. Products
  3. VOTRIENT 400

VOTRIENT 400

VOTRIENT IS INDICATED FOR THE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC). VOTRIENT IS INDICATED FOR THE TREATMENT OF PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA (STS) WHO HAVE RECEIVED PRIOR CHEMOTHERAPY.

  • STRENGTH : 400 MG
  • PACKAGING SIZE : 120 TAB
  • COMPOSITION : PAZOPANIB
  • MANUFACTURER : NOVARTIS
Category: